VERA
Price
$22.36
Change
+$1.22 (+5.77%)
Updated
Aug 13, 02:09 PM (EDT)
Capitalization
1.35B
84 days until earnings call
VYGR
Price
$3.69
Change
+$0.29 (+8.55%)
Updated
Aug 13, 03:09 PM (EDT)
Capitalization
188.04M
97 days until earnings call
Interact to see
Advertisement

VERA vs VYGR

Header iconVERA vs VYGR Comparison
Open Charts VERA vs VYGRBanner chart's image
Vera Therapeutics
Price$22.36
Change+$1.22 (+5.77%)
Volume$2.2K
Capitalization1.35B
Voyager Therapeutics
Price$3.69
Change+$0.29 (+8.55%)
Volume$1.25K
Capitalization188.04M
VERA vs VYGR Comparison Chart in %
Loading...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VERA vs. VYGR commentary
Aug 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VERA is a StrongBuy and VYGR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 13, 2025
Stock price -- (VERA: $21.14 vs. VYGR: $3.39)
Brand notoriety: VERA and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VERA: 100% vs. VYGR: 114%
Market capitalization -- VERA: $1.35B vs. VYGR: $188.04M
VERA [@Biotechnology] is valued at $1.35B. VYGR’s [@Biotechnology] market capitalization is $188.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VERA’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • VERA’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VERA’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 7 bullish TA indicator(s).

  • VERA’s TA Score: 5 bullish, 5 bearish.
  • VYGR’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than VERA.

Price Growth

VERA (@Biotechnology) experienced а +2.42% price change this week, while VYGR (@Biotechnology) price change was +0.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.35%. For the same industry, the average monthly price growth was +20.07%, and the average quarterly price growth was +19.98%.

Reported Earning Dates

VERA is expected to report earnings on Nov 05, 2025.

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+11.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.35B) has a higher market cap than VYGR($188M). VYGR YTD gains are higher at: -40.212 vs. VERA (-50.012). VYGR has higher annual earnings (EBITDA): -97.25M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. VYGR (236M). VYGR has less debt than VERA: VYGR (42M) vs VERA (54.5M). VYGR has higher revenues than VERA: VYGR (67M) vs VERA (0).
VERAVYGRVERA / VYGR
Capitalization1.35B188M718%
EBITDA-167.77M-97.25M173%
Gain YTD-50.012-40.212124%
P/E RatioN/A6.00-
Revenue067M-
Total Cash590M236M250%
Total Debt54.5M42M130%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VERAVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
82%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMDEX54.02N/A
N/A
Praxis Growth Index I
SGAAX23.35N/A
N/A
Virtus SGA Global Growth A
RYHOX80.63N/A
N/A
Rydex NASDAQ-100® H
GCEEX9.64N/A
N/A
Goldman Sachs Clean Energy Income R6
NRGEX62.89N/A
N/A
Neuberger Berman Genesis E